We are live on ! Find out more
HP

Hound Partners Portfolio holdings

AUM $875M Turnover 55%
1-Year Est. Return 2.71%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+2.71%
3 Year Est. Return
+28.25%
5 Year Est. Return
+14.86%
10 Year Est. Return
+195.96%
AUM
$4.59B
AUM Growth
+$69.3M
Cap. Flow
-$39.4M
Cap. Flow %
-0.86%
Top 10 Hldgs %
80.43%
Holding
30
New
2
Increased
14
Reduced
6
Closed
7
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
1.1 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.3 years
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
1.1 years

Top Sells

Rank Stock Value
1
SLXP
Salix Pharmaceuticals
SLXP
+$231M
2
ST icon
Sensata Technologies
ST
+$183M
3
CRI icon
Carter's
CRI
+$98.8M
4
TNET icon
TriNet
TNET
+$75.6M
5
INFA icon
Informatica
INFA
+$59.1M

Sector Composition

Rank Sector Weight
1 Healthcare 24.48%
2 Miscellaneous 19.14%
3 Consumer Discretionary 16.17%
4 Industrials 13.51%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BHC icon
1
Bausch Health
BHC
$3.08B
$608M 13.24%
+2,736,647
New +$607M
2015 Q2
0 quarters
SPR icon
2
DELISTED
Spirit AeroSystems
SPR
$560M 12.18%
10,152,694
+140,787
+1% +$7.54M
2014 Q1
5 quarters
C icon
3
CALL
Citigroup
C
$184B
$546M 11.88%
9,877,900
– –
2014 Q3
3 quarters
CRI icon
4
Carter's
CRI
$1.3B
$368M 8%
3,458,600
-984,890
-22% -$98.8M
2013 Q2
8 quarters
ANDV
5
DELISTED
Andeavor
ANDV
$324M 7.05%
3,835,352
+1,118,382
+41% +$97.1M
2013 Q2
8 quarters
CPAY icon
6
Corpay
CPAY
$27.6B
$313M 6.82%
2,007,296
+171,000
+9% +$26.8M
2013 Q2
8 quarters
ENOV icon
7
Enovis
ENOV
$1.48B
$259M 5.64%
3,260,282
+33,720
+1% +$2.86M
2013 Q2
8 quarters
IPXL
8
DELISTED
Impax Laboratories
IPXL
$258M 5.61%
5,612,348
+4,895,290
+683% +$232M
2015 Q1
1 quarter
CHTR icon
9
Charter Communications
CHTR
$14.8B
$231M 5.04%
1,351,594
-156,614
-10% -$28.2M
2013 Q2
8 quarters
KRFT
10
DELISTED
Kraft Foods Group
KRFT
$228M 4.97%
2,683,786
+1,672,360
+165% +$144M
2015 Q1
1 quarter
LKQ icon
11
LKQ
LKQ
$4.69B
$206M 4.48%
6,803,500
+4,104,232
+152% +$114M
2015 Q1
1 quarter
AIG icon
12
AIG
AIG
$41.5B
$182M 3.97%
2,947,465
-307,271
-9% -$18.2M
2013 Q2
8 quarters
C icon
13
Citigroup
C
$184B
$103M 2.23%
1,857,728
-50,763
-3% -$2.76M
2013 Q4
6 quarters
GRA
14
DELISTED
W.R. Grace & Co
GRA
$92.8M 2.02%
925,022
+50,607
+6% +$4.99M
2013 Q2
8 quarters
AIG.WS icon
15
DELISTED
AIG Warrants
AIG.WS
$72.1M 1.57%
2,601,041
+199,835
+8% +$4.97M
2013 Q2
8 quarters
ICE icon
16
Intercontinental Exchange
ICE
$95.6B
$62.3M 1.36%
1,392,770
+79,795
+6% +$3.7M
2014 Q3
3 quarters
TDG icon
17
TransDigm Group
TDG
$61.5B
$61.3M 1.33%
272,626
-262,763
-49% -$58.9M
2013 Q2
8 quarters
QSR icon
18
Restaurant Brands International
QSR
$25.5B
$58.5M 1.27%
1,530,657
+534,883
+54% +$21.1M
2015 Q1
1 quarter
TCOM icon
19
Trip.com Group
TCOM
$25.7B
$18.2M 0.4%
500,000
-1,043,238
-68% -$36.4M
2014 Q3
3 quarters
WIN
20
PUT
DELISTED
Windstream Holdings
WIN
$14M 0.31%
440,000
+159,133
+57% +$7.58M
2015 Q1
1 quarter
KING
21
DELISTED
King Digital Entertainment
KING
$10.6M 0.23%
+741,232
New +$11.5M
2015 Q2
0 quarters
XIV
22
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
$10.2M 0.22%
251,487
+15,404
+7% +$659K
2013 Q2
8 quarters
KING
23
PUT
DELISTED
King Digital Entertainment
KING
$8.55M 0.19%
600,000
+300,000
+100% +$4.65M
2015 Q1
1 quarter
AXTA icon
24
Axalta
AXTA
$7.32B
– –
-15,000
Closed -$414K –
ST icon
25
Sensata Technologies
ST
$5.18B
– –
-3,191,604
Closed -$183M –

Similar funds

Hound Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Hound Partners held 30 positions worth $4.59B, up 1.5% from $4.52B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Hound Partners's Q2 2015 filing shows 2 new, 14 increased, 6 reduced and 7 closed positions. Its largest new stake was Bausch Health: 2,736,647 shares worth $608M. The largest sale was Salix Pharmaceuticals, an estimated $231M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 6.6% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Hound Partners's largest Q2 2015 buy was Bausch Health: 2,736,647 shares worth $608M.
  • Hound Partners added most to Impax Laboratories in Q2 2015, an estimated $232M increase.
  • Hound Partners's biggest Q2 2015 reduction was Carter's, cutting an estimated $98.8M.
  • Hound Partners fully exited Salix Pharmaceuticals in Q2 2015, selling an estimated $231M.
  • Hound Partners's ten largest holdings make up 80% of its $4.59B portfolio in Q2 2015.
  • Hound Partners opened 2 new positions and closed 7 in Q2 2015.
  • Hound Partners's portfolio value rose 1.5% quarter-over-quarter to $4.59B.

Based on Hound Partners's 13F filing for Q2 2015, filed 14 Aug 2015.